Aging reduces NAD+ synthesis pathways while increasing consumption by enzymes like CD38 and PARPs, activated by inflammation and damage.[13][15] CD38, an immune-related enzyme, ramps up with age, breaking down NAD+ precursors
Experimental investigations have examined the relationship between NNMT inhibition and regulatory pathways involving nicotinamide turnover, methylation dynamics, transcriptional control mechanisms, and downstream signal transduction processes
Plain-English summary: 5-Amino-1MQ and AOD-9604 both target fat without touching appetite
NNMT also lowers NAD+, affecting how our bodies use energy and handle fat
Common Dosage and Cycling Protocols While every protocol should be personalized, a frequently cited dosage for 5-Amino-1MQ is 50mg, taken one to three times per day, often with meals to support absorption